A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants-Reference-Cited by-同舟云学术

A nasal omicron vaccine booster elicits potent neutralizing antibody response against emerging SARS-CoV-2 variants

Published:2022-03-30 Issue:1 Volume:11 Page:964-967
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Lam Joy-Yan¹,Ng Yau-Yee¹,Yuen Chun-Kit¹²^ORCID,Wong Wan-Man¹³,Yuen Kwok-Yung¹²³^ORCID,Kok Kin-Hang¹²³^ORCID

Affiliation:

1. Department of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, People’s Republic of China

2. Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR, People’s Republic of China

3. State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, People’s Republic of China

Funder

Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong SAR

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2053365

Reference13 articles.

1. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant

2. Heavily mutated Omicron variant puts scientists on alert

3. National Center for Immunization and Respiratory Diseases (NCIRD) DoVD. Science Brief: Omicron (B.1.1.529) Variant. Centers for Disease Control and Prevention2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/science/science-briefs/scientific-brief-omicron-variant.html.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Key to Increase Immunogenicity of Next-Generation COVID-19 Vaccines Lies in the Inclusion of the SARS-CoV-2 Nucleocapsid Protein;Journal of Immunology Research;2024-05-29

2. Effect of vaccine dose on severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) antibody levels in a vaccinated community in Gowa Regency, Indonesia;Journal of Education and Health Promotion;2024-02

3. Overview of Nucleocapsid-Targeting Vaccines against COVID-19;Vaccines;2023-12-03

4. Use of a point-of-care test to rapidly assess levels of SARS-CoV-2 nasal neutralising antibodies in vaccinees and breakthrough infected individuals;Scientific Reports;2023-11-20

5. Intranasal boosting with RBD-HR protein vaccine elicits robust mucosal and systemic immune responses;Genes & Diseases;2023-08